EQS-News: Heidelberg Pharma AG
/ Key word(s): Conference
Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2025
04.09.2025 / 09:46 CET/CEST
The issuer is solely responsible for…Read More
You might also be interested in reading Ethereum Price Consolidates and Eyes Recovery—Is a Bounce Incoming?.